milrinone has been researched along with Cerebral Infarction in 5 studies
Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intravenous and intra-arterial milrinone as a rescue measure for delayed cerebral ischemia (DCI) after subarachnoid hemorrhage (SAH) has been adopted by several groups, but so far, evidence for the clinical benefit is unclear and effect on brain perfusion is unknown." | 8.12 | Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage. ( Andereggen, L; Berberat, J; Ensner, R; Marbacher, S; Remonda, L; Steiger, HJ, 2022) |
| "The role of nimodipine and milrinone in the management of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (SAH) was studied using clinical and TCD (transcranial Doppler) parameters." | 8.12 | Role of Nimodipine and Milrinone in Delayed Cerebral Ischemia. ( Chakrabarti, D; Konar, SK; Kotwal, A; Radhakrishnan, M; Ramalingaiah, AH; Shukla, D; Srinivasaiah, B; Sundaram, M, 2022) |
| "Delayed cerebral ischemia (DCI) is a complication of aneurysmal subarachnoid hemorrhage (aSAH) and is associated with significant morbidity and mortality." | 5.91 | Subarachnoid Hemorrhage, Delayed Cerebral Ischemia, and Milrinone Use in Canada. ( Almojuela, A; Bokhari, R; Christie, SD; Duda, T; Eagles, ME; Elkaim, LM; Iorio-Morin, C; Kameda-Smith, MM; Lownie, SP; MacLean, MA; Persad, ARL; Rizzuto, MA; Teitelbaum, J, 2023) |
| "DIND, delayed cerebral infarction (DCI), and modified Rankin scale at 3 months after SAH were used for the assessment of outcome." | 5.40 | Milrinone via lumbar subarachnoid catheter for vasospasm after aneurysmal subarachnoid hemorrhage. ( Chin, M; Narumi, O; Sadamasa, N; Yamagata, S; Yoshida, K, 2014) |
| "Intravenous and intra-arterial milrinone as a rescue measure for delayed cerebral ischemia (DCI) after subarachnoid hemorrhage (SAH) has been adopted by several groups, but so far, evidence for the clinical benefit is unclear and effect on brain perfusion is unknown." | 4.12 | Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage. ( Andereggen, L; Berberat, J; Ensner, R; Marbacher, S; Remonda, L; Steiger, HJ, 2022) |
| "The role of nimodipine and milrinone in the management of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (SAH) was studied using clinical and TCD (transcranial Doppler) parameters." | 4.12 | Role of Nimodipine and Milrinone in Delayed Cerebral Ischemia. ( Chakrabarti, D; Konar, SK; Kotwal, A; Radhakrishnan, M; Ramalingaiah, AH; Shukla, D; Srinivasaiah, B; Sundaram, M, 2022) |
| "Delayed cerebral ischemia (DCI) is a complication of aneurysmal subarachnoid hemorrhage (aSAH) and is associated with significant morbidity and mortality." | 1.91 | Subarachnoid Hemorrhage, Delayed Cerebral Ischemia, and Milrinone Use in Canada. ( Almojuela, A; Bokhari, R; Christie, SD; Duda, T; Eagles, ME; Elkaim, LM; Iorio-Morin, C; Kameda-Smith, MM; Lownie, SP; MacLean, MA; Persad, ARL; Rizzuto, MA; Teitelbaum, J, 2023) |
| "DIND, delayed cerebral infarction (DCI), and modified Rankin scale at 3 months after SAH were used for the assessment of outcome." | 1.40 | Milrinone via lumbar subarachnoid catheter for vasospasm after aneurysmal subarachnoid hemorrhage. ( Chin, M; Narumi, O; Sadamasa, N; Yamagata, S; Yoshida, K, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steiger, HJ | 1 |
| Ensner, R | 1 |
| Andereggen, L | 1 |
| Remonda, L | 1 |
| Berberat, J | 1 |
| Marbacher, S | 1 |
| Eagles, ME | 1 |
| MacLean, MA | 1 |
| Kameda-Smith, MM | 1 |
| Duda, T | 1 |
| Persad, ARL | 1 |
| Almojuela, A | 1 |
| Bokhari, R | 1 |
| Iorio-Morin, C | 1 |
| Elkaim, LM | 1 |
| Rizzuto, MA | 1 |
| Lownie, SP | 1 |
| Christie, SD | 1 |
| Teitelbaum, J | 1 |
| Kotwal, A | 1 |
| Ramalingaiah, AH | 1 |
| Shukla, D | 1 |
| Radhakrishnan, M | 1 |
| Konar, SK | 1 |
| Srinivasaiah, B | 1 |
| Chakrabarti, D | 1 |
| Sundaram, M | 1 |
| Castle-Kirszbaum, M | 1 |
| Lai, L | 1 |
| Maingard, J | 1 |
| Asadi, H | 1 |
| Danks, RA | 1 |
| Goldschlager, T | 1 |
| Chandra, RV | 1 |
| Sadamasa, N | 1 |
| Yoshida, K | 1 |
| Narumi, O | 1 |
| Chin, M | 1 |
| Yamagata, S | 1 |
1 review available for milrinone and Cerebral Infarction
| Article | Year |
|---|---|
Intravenous milrinone for treatment of delayed cerebral ischaemia following subarachnoid haemorrhage: a pooled systematic review.
Topics: Brain Ischemia; Cerebral Infarction; Female; Humans; Male; Middle Aged; Milrinone; Pharmaceutical Pr | 2021 |
4 other studies available for milrinone and Cerebral Infarction
| Article | Year |
|---|---|
Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Topics: Brain Ischemia; Cerebral Infarction; Hemodynamics; Humans; Hypertension; Milrinone; Nimodipine; Nore | 2022 |
Subarachnoid Hemorrhage, Delayed Cerebral Ischemia, and Milrinone Use in Canada.
Topics: Brain Ischemia; Canada; Cerebral Infarction; Cross-Sectional Studies; Humans; Milrinone; Subarachnoi | 2023 |
Role of Nimodipine and Milrinone in Delayed Cerebral Ischemia.
Topics: Brain Ischemia; Cerebral Infarction; Humans; Milrinone; Nimodipine; Subarachnoid Hemorrhage; Vasospa | 2022 |
Milrinone via lumbar subarachnoid catheter for vasospasm after aneurysmal subarachnoid hemorrhage.
Topics: Aged; Cerebral Angiography; Cerebral Infarction; Female; Humans; Infusions, Spinal; Lumbar Vertebrae | 2014 |